Birmingham Experimental Cancer Medicine Centre

The Birmingham Experimental Cancer Medicine Centre (ECMC) drives the delivery of our novel cancer research, translating Birmingham-led discovery science in fields such as genomics and immunology, into the clinic. Jointly funded by Cancer Research UK and the National Institute for Health and Care Research, we deliver our research within a national network of leading cancer centres. Our Centre Director Professor Gary Middleton has a pivotal role in setting the future direction for cancer precision medicine, and drives the development of novel trials informed by Birmingham immunological discoveries.

Also in 'Birmingham Experimental Cancer Medicine Centre'